NRIX
Nurix Therapeutics, Inc.CIK 0001549595
Showing the last 10 days.Sign up free for 90 days
Insider trades
View all NRIX insider trades| Type | Insider | Shares | Price | Value | Traded | Filed |
|---|---|---|---|---|---|---|
| Exercise | van Houte Hans Chief Financial Officer | 10,182 | — | Oct 30, 2026 | Nov 3, 2026 | |
| Sell | van Houte Hans Chief Financial Officer | 2,834 | $74K | Oct 30, 2026 | Nov 3, 2026 | |
| Exercise | Ring Christine Chief Legal Officer | 10,182 | — | Oct 30, 2026 | Nov 3, 2026 | |
| Sell | Ring Christine Chief Legal Officer | 3,957 | $104K | Oct 30, 2026 | Nov 3, 2026 | |
| Exercise | Hansen Gwenn Chief Scientific Officer | 11,634 | $3K | Nov 2, 2026 | Nov 3, 2026 | |
| Sell | Hansen Gwenn Chief Scientific Officer | 5,409 | $143K | Nov 2, 2026 | Nov 3, 2026 |
Earnings
PaidCompany revenue, EPS, net income, and guidance the moment they file, parsed from SEC 8-K earnings releases. Create a free account to get started, then unlock earnings on a paid plan.
- Revenue and adjusted / GAAP EPS per quarter
- GAAP net income with profit and loss at a glance
- Forward EPS guidance when companies provide it